These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 16115862)
1. Two HLA-B14 subtypes (B*1402 and B*1403) differentially associated with ankylosing spondylitis differ substantially in peptide specificity but have limited peptide and T-cell epitope sharing with HLA-B27. Merino E; Montserrat V; Paradela A; López de Castro JA J Biol Chem; 2005 Oct; 280(43):35868-80. PubMed ID: 16115862 [TBL] [Abstract][Full Text] [Related]
2. Differential association of HLA-B*2705 and B*2709 to ankylosing spondylitis correlates with limited peptide subsets but not with altered cell surface stability. Ramos M; Paradela A; Vazquez M; Marina A; Vazquez J; Lopez de Castro JA J Biol Chem; 2002 Aug; 277(32):28749-56. PubMed ID: 12042320 [TBL] [Abstract][Full Text] [Related]
3. The peptide repertoires of HLA-B27 subtypes differentially associated to spondyloarthropathy (B*2704 and B*2706) differ by specific changes at three anchor positions. Sesma L; Montserrat V; Lamas JR; Marina A; Vázquez J; López de Castro JA J Biol Chem; 2002 May; 277(19):16744-9. PubMed ID: 11875071 [TBL] [Abstract][Full Text] [Related]
4. Allospecific T cell epitope sharing reveals extensive conservation of the antigenic features of peptide ligands among HLA-B27 subtypes differentially associated with spondyloarthritis. Montserrat V; Martí M; López de Castro JA J Immunol; 2003 Jun; 170(11):5778-85. PubMed ID: 12759462 [TBL] [Abstract][Full Text] [Related]
5. B*2707 differs in peptide specificity from B*2705 and B*2704 as much as from HLA-B27 subtypes not associated to spondyloarthritis. Gómez P; Montserrat V; Marcilla M; Paradela A; de Castro JA Eur J Immunol; 2006 Jul; 36(7):1867-81. PubMed ID: 16783853 [TBL] [Abstract][Full Text] [Related]
6. Large sharing of T-cell epitopes and natural ligands between HLA-B27 subtypes (B*2702 and B*2705) associated with spondyloarthritis. Martí M; Alvarez I; Montserrat V; López de Castro JA Tissue Antigens; 2001 Dec; 58(6):351-62. PubMed ID: 11929585 [TBL] [Abstract][Full Text] [Related]
7. High T cell epitope sharing between two HLA-B27 subtypes (B*2705 and B*2709) differentially associated to ankylosing spondylitis. García-Peydró M; Martí M; López de Castro JA J Immunol; 1999 Aug; 163(4):2299-305. PubMed ID: 10438975 [TBL] [Abstract][Full Text] [Related]
8. Modulation at multiple anchor positions of the peptide specificity of HLA-B27 subtypes differentially associated with ankylosing spondylitis. Lamas JR; Paradela A; Roncal F; López de Castro JA Arthritis Rheum; 1999 Sep; 42(9):1975-85. PubMed ID: 10513815 [TBL] [Abstract][Full Text] [Related]
9. Peptide handling by HLA-B27 subtypes influences their biological behavior, association with ankylosing spondylitis and susceptibility to endoplasmic reticulum aminopeptidase 1 (ERAP1). García-Medel N; Sanz-Bravo A; Alvarez-Navarro C; Gómez-Molina P; Barnea E; Marcilla M; Admon A; de Castro JA Mol Cell Proteomics; 2014 Dec; 13(12):3367-80. PubMed ID: 25187574 [TBL] [Abstract][Full Text] [Related]
10. Identification of novel HLA-B27 ligands derived from polymorphic regions of its own or other class I molecules based on direct generation by 20 S proteasome. Alvarez I; Sesma L; Marcilla M; Ramos M; Marti M; Camafeita E; de Castro JA J Biol Chem; 2001 Aug; 276(35):32729-37. PubMed ID: 11435436 [TBL] [Abstract][Full Text] [Related]
11. Dual, HLA-B27 subtype-dependent conformation of a self-peptide. Hülsmeyer M; Fiorillo MT; Bettosini F; Sorrentino R; Saenger W; Ziegler A; Uchanska-Ziegler B J Exp Med; 2004 Jan; 199(2):271-81. PubMed ID: 14734527 [TBL] [Abstract][Full Text] [Related]
12. The Cys-67 residue of HLA-B27 influences cell surface stability, peptide specificity, and T-cell antigen presentation. Alvarez I; Martí M; Vázquez J; Camafeita E; Ogueta S; López de Castro JA J Biol Chem; 2001 Dec; 276(52):48740-7. PubMed ID: 11673468 [TBL] [Abstract][Full Text] [Related]
13. The South Amerindian allotype HLA-B*3909 has the largest known similarity in peptide specificity and common natural ligands with HLA-B27. Yagüe J; Ramos M; Vázquez J; Marina A; Albar JP; López de Castro JA Tissue Antigens; 1999 Mar; 53(3):227-36. PubMed ID: 10203015 [TBL] [Abstract][Full Text] [Related]
14. Structural basis for T cell alloreactivity among three HLA-B14 and HLA-B27 antigens. Kumar P; Vahedi-Faridi A; Saenger W; Merino E; López de Castro JA; Uchanska-Ziegler B; Ziegler A J Biol Chem; 2009 Oct; 284(43):29784-97. PubMed ID: 19617632 [TBL] [Abstract][Full Text] [Related]
15. Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes. Fiorillo MT; Meadows L; D'Amato M; Shabanowitz J; Hunt DF; Appella E; Sorrentino R Eur J Immunol; 1997 Feb; 27(2):368-73. PubMed ID: 9045906 [TBL] [Abstract][Full Text] [Related]
16. Qualitative and quantitative differences in peptides bound to HLA-B27 in the presence of mouse versus human tapasin define a role for tapasin as a size-dependent peptide editor. Sesma L; Galocha B; Vázquez M; Purcell AW; Marcilla M; McCluskey J; López de Castro JA J Immunol; 2005 Jun; 174(12):7833-44. PubMed ID: 15944288 [TBL] [Abstract][Full Text] [Related]
18. Changes in the repertoire of peptides bound to HLA-B27 subtypes and to site-specific mutants inside and outside pocket B. Rojo S; García F; Villadangos JA; López de Castro JA J Exp Med; 1993 Mar; 177(3):613-20. PubMed ID: 8436905 [TBL] [Abstract][Full Text] [Related]
19. Conformational dimorphism of self-peptides and molecular mimicry in a disease-associated HLA-B27 subtype. Rückert C; Fiorillo MT; Loll B; Moretti R; Biesiadka J; Saenger W; Ziegler A; Sorrentino R; Uchanska-Ziegler B J Biol Chem; 2006 Jan; 281(4):2306-16. PubMed ID: 16221670 [TBL] [Abstract][Full Text] [Related]
20. Limited diversity of peptides related to an alloreactive T cell epitope in the HLA-B27-bound peptide repertoire results from restrictions at multiple steps along the processing-loading pathway. Paradela A; Alvarez I; García-Peydró M; Sesma L; Ramos M; Vázquez J; López De Castro JA J Immunol; 2000 Jan; 164(1):329-37. PubMed ID: 10605027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]